These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29116117)
21. Small RNA Deep Sequencing Identifies a Unique miRNA Signature Released in Serum Exosomes in a Mouse Model of Sjögren's Syndrome. Kakan SS; Janga SR; Cooperman B; Craig DW; Edman MC; Okamoto CT; Hamm-Alvarez SF Front Immunol; 2020; 11():1475. PubMed ID: 32849505 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas. Sápi Z; Papp G; Szendrői M; Pápai Z; Plótár V; Krausz T; Fletcher CD Genes Chromosomes Cancer; 2016 Oct; 55(10):786-802. PubMed ID: 27223121 [TBL] [Abstract][Full Text] [Related]
23. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy. Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294 [TBL] [Abstract][Full Text] [Related]
24. Identification of altered MicroRNA expression patterns in synovial sarcoma. Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367 [TBL] [Abstract][Full Text] [Related]
25. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897 [TBL] [Abstract][Full Text] [Related]
27. Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy. Wu T; Chen Y; Du Y; Tao J; Zhou Z; Yang Z Cell Physiol Biochem; 2018; 46(5):1939-1950. PubMed ID: 29719295 [TBL] [Abstract][Full Text] [Related]
28. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
30. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series. Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780 [TBL] [Abstract][Full Text] [Related]
31. Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence. Nakano T; Chen IH; Wang CC; Chen PJ; Tseng HP; Huang KT; Hu TH; Li LC; Goto S; Cheng YF; Lin CC; Chen CL Am J Transplant; 2019 Dec; 19(12):3250-3262. PubMed ID: 31162867 [TBL] [Abstract][Full Text] [Related]
32. miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo. Gong L; Ren M; Lv Z; Yang Y; Wang Z DNA Cell Biol; 2018 May; 37(5):501-511. PubMed ID: 29638162 [TBL] [Abstract][Full Text] [Related]
33. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845 [TBL] [Abstract][Full Text] [Related]
34. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605 [TBL] [Abstract][Full Text] [Related]
35. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma. Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505 [TBL] [Abstract][Full Text] [Related]
37. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952 [TBL] [Abstract][Full Text] [Related]
38. Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus. Goswami S; Banerjee A; Kumari B; Bandopadhyay B; Bhattacharya N; Basu N; Vrati S; Banerjee A Mol Neurobiol; 2017 Mar; 54(2):1541-1551. PubMed ID: 26860411 [TBL] [Abstract][Full Text] [Related]